M. Bishr Omary, MD, PhD, AGAF, received his undergraduate degree from George Mason University, his PhD in chemistry from the University of California, San Diego (UCSD) and his MD from the University of Miami. After internal medicine residency at the University of California, Irvine, and fellowship in gastroenterology at UCSD, he moved to Stanford University where he was for 19 years. While at Stanford, he served as chief of the division of gastroenterology and hepatology and director of its NIH funded P30 digestive disease center and its T32 training program.
In 2008, Dr. Omary moved to the University of Michigan Medical School where he served in several capacities chair of its Department of Molecular and Integrative Physiology, and as Executive Vice Dean for Research and Chief Scientific Officer. In August 2019, he began a new role as Senior Vice Chancellor for Academic Affairs and Research at Rutgers Biomedical and Health Sciences, Rutgers University. He is an elected member of the American Society for Clinical Investigation, the American Association of Physicians, and the American Association for the Advancement of Science, and has received several mentoring and teaching awards from Stanford University, the University of Michigan and AGA. He is an internationally recognized biomedical investigator and his currently active laboratory studies the pathogenesis, therapeutic approaches and biomarkers related to intermediate filament proteins and their associated diseases and to porphyrias.
Dr. Omary has been involved with AGA in several capacities. He has served as member of several committees, including chairing the AGA Institute Research Awards Panel, and served as associate editor (2006-2011) then editor-in-chief (2011-2016) of Gastroenterology. Currently, Dr. Omary is a member of the AGA Institute Governing Board and is in line to become president of AGA in May 2020.